Response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone
Crossref DOI link: https://doi.org/10.1186/s40425-017-0236-3
Published Online: 2017-04-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosner, Samuel
Sen, Filiz
Postow, Michael